)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Linc
Linc (LINC) investor relations material
Linc Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary22 Oct, 2026
Executive summary
Portfolio NAV per share returned 2.2% in Q3 and 4.1% in 9M 2026; aggregate asset values were broadly flat in Q3 despite significant movements in individual holdings.
9M management result was SEK 192.9m, versus a loss of SEK 292.5m a year earlier, reflecting portfolio value gains and stronger listed holdings.
Investment activity remained selective and long-term; additional purchases increased positions in Sedana Medical and OssDsign, among others.
Financial highlights
Q3 management result was SEK 110.8m (SEK 354.3m); EBIT was SEK 107.7m (SEK 351.0m), and net income was SEK 99.5m (SEK 353.7m).
Q3 EPS was SEK 1.7 (SEK 6.1); NAV increased SEK 99.5m and NAV per share returned 2.2% (8.5%).
9M management result was SEK 192.9m (loss of SEK 292.5m); EBIT was SEK 183.1m (loss of SEK 302.1m), and net income was SEK 180.7m (loss of SEK 291.5m).
9M EPS was SEK 3.1 (loss of SEK 5.0); NAV per share returned 4.1%, compared with -6.0% in 9M 2025.
Outlook and guidance
Sedana Medical’s FDA application review has an April 16, 2027 target decision date; US approval could unlock significant sales potential.
Cinclus Pharma completed all patient follow-up visits in its Phase III study and expected topline results in Q4 2026.
Oncoinvent’s interim study readout was anticipated in early 2027; management saw long-term value potential across portfolio companies with clinical and commercial prospects.
Management highlighted ongoing acquisition activity in biotech and continued operating progress at portfolio companies, while noting uncertainty around the cost of long-term capital.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Linc
- NAV per share up 6.1% in Q2 2026, with strong results from MedCap and Stille.LINC
Q2 2026 - NAV per share declined 4.0% in Q1 2026, with improved results and selective portfolio gains.LINCQ1 2026
- Sharp decline in net asset value and earnings in 2025, with no dividend proposed.LINCQ4 2025
- Strong Q3 rebound with 8.5% NAV return, MedCap leads gains, biotech sector shows early recovery.LINCQ3 2025
- H1 2025 marked sharp portfolio swings but Q2 recovery and strategic investments support future growth.LINCQ2 2025
- 30.9% NAV return YTD, major Calliditas exit, strong MedCap and Stille, biotech lagged.LINCQ3 2024
- Q2 net profit surged to SEK 1,040.9m with 29% NAV return, led by MedCap and Calliditas.LINCQ2 2024
- Net asset value return fell to -20.6% as MedCap and Sedana Medical saw sharp declines.LINCQ1 2025
- Net asset value per share surged 36.9% in 2024, led by MedCap and Calliditas gains.LINCQ4 2024
Next Linc earnings date
Q4 202621 Jan, 2027
Linc
Next Linc earnings date
Q4 202621 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments. Linc operates in Sweden, focusing on investments in technologies or companies that have the potential to become clear world leaders. Link ABs investments are spread across our different brands - Linc Ventures, NB Ventures, HVB Group and Hamburg Invest. Linc AB is headquartered in Stockholm, Sweden.